13F-HR filed by Sofinnova Investments, Inc.
Sofinnova Investments, Inc. filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-08, with 58 holding rows worth $1,718,697,000.
- Accession
- 0001104659-22-115835
- Filer
- CIK 1631134
- Filed
- 2022-11-08
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2022
A holdings report, 61 entries on the cover page, a total value of $1,718,697,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,718,697,000 with VALUE read as thousands by filing date, 13F file number 028-18774. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 2,073,124 | $466,308,000 | thousands by filing date | |
| CINCOR PHARMA INC | 17240Y109 | COM | 6,079,949 | $199,544,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 3,102,960 | $135,972,000 | thousands by filing date | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 3,181,442 | $67,797,000 | thousands by filing date | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 3,758,686 | $62,319,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 499,824 | $51,612,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 583,468 | $50,248,000 | thousands by filing date | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 1,264,546 | $48,078,000 | thousands by filing date | |
| INVESCO QQQ TR | 46090E103 | COM | 150,000 | $40,089,000 | thousands by filing date | put |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 701,878 | $38,491,000 | thousands by filing date | |
| Health Care Select Sector SPDR Fund | 81369Y209 | SHS | 300,000 | $36,333,000 | thousands by filing date | put |
| iShares Russell 2000 ETF | 464287655 | SHS | 200,000 | $32,984,000 | thousands by filing date | put |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 2,194,278 | $31,641,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 147,564 | $30,897,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 482,400 | $29,759,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 300,000 | $25,836,000 | thousands by filing date | call |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 294,750 | $24,986,000 | thousands by filing date | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 3,612,376 | $21,024,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 818,376 | $20,566,000 | thousands by filing date | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 96,300 | $18,050,000 | thousands by filing date | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 140,095 | $17,551,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 205,948 | $16,587,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 141,440 | $15,635,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 320,722 | $15,539,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 820,665 | $14,723,000 | thousands by filing date | |
| Eli Lilly and Company | 532457108 | COM | 45,500 | $14,712,000 | thousands by filing date | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 583,357 | $12,636,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 525,002 | $12,616,000 | thousands by filing date | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 147,200 | $12,163,000 | thousands by filing date | |
| AKOUOS INC | 00973J101 | COM | 1,515,074 | $10,242,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 381,345 | $9,976,000 | thousands by filing date | |
| INOZYME PHARMA INC | 45790W108 | COM | 3,655,308 | $9,796,000 | thousands by filing date | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 654,756 | $9,769,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 394,678 | $9,725,000 | thousands by filing date | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 139,774 | $8,248,000 | thousands by filing date | |
| INHIBRX INC | 45720L107 | COM | 450,177 | $8,081,000 | thousands by filing date | |
| NEXTCURE INC | 65343E108 | COM | 2,671,856 | $7,348,000 | thousands by filing date | |
| ADICET BIO INC | 007002108 | COM | 491,965 | $6,996,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 797,262 | $6,450,000 | thousands by filing date | |
| INHIBRX INC | 45720L107 | COM | 350,000 | $6,283,000 | thousands by filing date | put |
| NUCANA PLC | 67022C106 | ADR | 5,599,999 | $5,852,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 287,901 | $5,660,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 213,959 | $5,655,000 | thousands by filing date | |
| GALERA THERAPEUTICS EQUICLASS EQUITY | 36338D108 | COMMON STOCK | 3,083,712 | $5,366,000 | thousands by filing date | |
| IMMATICS N.V | N44445109 | SHS | 532,516 | $5,325,000 | thousands by filing date | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 274,330 | $5,242,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 2,437,465 | $4,997,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 220,665 | $4,753,000 | thousands by filing date | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 2,754,437 | $4,077,000 | thousands by filing date | |
| GERON CORP | 374163103 | COM | 1,189,208 | $2,783,000 | thousands by filing date | |
| GERON CORP | 374163103 | COM | 1,072,100 | $2,509,000 | thousands by filing date | call |
| Nucana PLC | GB00BYWYV | COMMON SHARES | 2,400,000 | $2,508,000 | thousands by filing date | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 502,393 | $2,401,000 | thousands by filing date | |
| NGM BIOPHARMACEUTICALS INC | 62921N105 | COM | 150,000 | $1,962,000 | thousands by filing date | call |
| ObsEva SA | H5861P103 | COM | 4,749,623 | $675,000 | thousands by filing date | |
| SYNLOGIC INC | 87166L100 | COM | 574,972 | $546,000 | thousands by filing date | |
| PDS BIOTECHNOLOGY CORP | 70465T107 | COM | 142,635 | $424,000 | thousands by filing date | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 117,099 | $352,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-22-115835 | this filing | 2022-11-08 | acceptance time not in the bulk data set |